JEV IC51

inactivated Japanese encephalitis vaccine IC51 · Valneva Austria GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JEV IC51, covering 2014-01-23 to 2014-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling [Phase 3]